首页> 外文期刊>Oncology letters >Malignant transformation of hyperplastic gastric polyps: An immunohistochemical and pathological study of the changes of neoplastic phenotype
【24h】

Malignant transformation of hyperplastic gastric polyps: An immunohistochemical and pathological study of the changes of neoplastic phenotype

机译:增生性胃息肉的恶性转化:肿瘤表型变化的免疫组织化学和病理学研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In spite of the evidence that the malignant transformation of gastric hyperplastic polyps (HPs) is a rare event, it must always be taken into account during diagnosis. The aim of the current study was to clarify the mechanism of the malignant transformation of gastric hyperplasia polyps, with focus on phenotypic expression, cell proliferation and p53 overexpression. Immunohistochemistry for mucin phenotypic markers, including MUC1, MUC2, MUC5AC, MUC6, tight junction factors (claudin-3, -4 and -18), an intestinal phenotypic marker [caudal type homeobox 2 (Cdx2)], Ki-67 proliferative index and p53 overexpression, was performed on archival specimens of gastric polyps excised from six patients. Histologically, the intermingled components of several lesions were present in these polyps. Furthermore, the cancer components were predominantly differentiated adenocarcinoma. Immunohistochemically, all hyperplastic components expressed MUC5AC, but did not exhibit positivity for MUC2. Additionally, the majority of hyperplastic components were immunonegative for claudin-3, while claudin-3 positivity was observed in the majority of areas of dysplasia and carcinoma. Expression of claudin-4 was also observed in the majority of cases and claudin-18 was preserved in the hyperplastic, dysplastic and adenocarcinomatous lesions of all cases. Nuclear accumulation of Cdx2 was detected in almost all the samples with dysplasia and carcinoma, while nuclear p53 was detected in 24-80% of the dysplastic areas and >85% of the cancer components. The Ki-67 labeling index appeared to correlate with neoplastic progression. The observations provided evidence that the mechanism underlying malignant transformation of gastric HPs may occur by multistep carcinogenesis, such as the hyperplasia-adenoma (dysplasia)-adenocarcinoma sequence, and these neoplastic cells may acquire various phenotypes during this process.
机译:尽管有证据表明胃增生性息肉(HPs)发生恶变是罕见的事件,但在诊断过程中必须始终将其考虑在内。本研究的目的是阐明胃增生性息肉的恶性转化机制,重点是表型表达,细胞增殖和p53过表达。粘蛋白表型标志物的免疫组织化学,包括MUC1,MUC2,MUC5AC,MUC6,紧密连接因子(claudin-3,-4和-18),肠道表型标志物[尾型同源盒2(Cdx2)],Ki-67增殖指数和在从6例患者中切除的胃息肉的存档标本上进行了p53过表达。从组织学上看,这些息肉中存在多种病变的混合成分。此外,癌症成分主要是分化的腺癌。免疫组织化学分析,所有增生成分均表达MUC5AC,但未显示MUC2阳性。此外,大多数增生成分对claudin-3呈免疫阴性,而在大多数不典型增生和癌变区域中claudin-3阳性。在大多数病例中也观察到claudin-4的表达,并且claudin-18在所有病例的增生,增生和腺癌病变中均得以保留。几乎在所有具有不典型增生和癌的样本中都检测到Cdx2的核积累,而在不典型增生区域的24-80%和癌成分的> 85%中检测到了核p53。 Ki-67标记指数似乎与肿瘤进展相关。这些发现提供了证据,表明胃HPs恶性转化的潜在机制可能是通过多步骤癌变而发生的,例如增生-腺瘤(不典型增生)-腺癌序列,并且这些赘生性细胞在此过程中可能获得各种表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号